<DOC>
	<DOCNO>NCT00467896</DOCNO>
	<brief_summary>A Comparison Safety Inhalation Times Ventavis ( iloprost ) Inhalation Solution deliver I-Neb Utilizing Power Disc-6 Power Disc-15 `` Power 15 Study ''</brief_summary>
	<brief_title>The `` Power 15 Study '' : Safety Study Inhalation Ventavis With Power Disc-15 Setting</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Hypertension , Pulmonary</mesh_term>
	<mesh_term>Iloprost</mesh_term>
	<criteria>Male female , age 1885 year Have current diagnosis symptomatic pulmonary arterial hypertension ( PAH ) classify one following : ) idiopathic pulmonary arterial hypertension ( IPAH ) familial pulmonary arterial hypertension ( FPAH ) ; b ) PAH associate one follow connective tissue diseases mild lung parenchymal disease : scleroderma spectrum disease , systemic lupus erythematosis , mixed connective tissue disease , c ) PAH associate repair atrial septal defect ( ASD ) , ventricular septal defect ( VSD ) , patent ductus arteriosis ( PDA ) ≥ 1 year postoperative Screening , ) PAH associate human immunodeficiency virus ( HIV ) , e ) PAH associate use anorexigens ( e.g . fenfluraminephentermine ) On stable well tolerate dose regimen Ventavis ( 5 μg per dose ) least 4 week prior Screening visit , use Ineb AAD System equip Power Disc6 Receipt prostacyclin prostacyclin analogue Ventavis within 12 week precede Screening visit Receipt atrial septostomy within 6 month precede Screening History leftsided heart disease Clinically relevant obstructive lung disease Chronic renal liver disease Uncontrolled systemic hypertension hypotension Cerebrovascular event within 6 month precede Screening</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>March 2013</verification_date>
	<keyword>PAH</keyword>
	<keyword>iloprost</keyword>
	<keyword>Ventavis</keyword>
	<keyword>Pulmonary Arterial Hypertension</keyword>
	<keyword>Actelion Pharmaceuticals</keyword>
	<keyword>Cotherix</keyword>
</DOC>